Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 16, 2021

SELL
$56.61 - $80.46 $937,914 - $1.33 Million
-16,568 Closed
0 $0
Q1 2021

May 14, 2021

SELL
$86.23 - $125.19 $930,335 - $1.35 Million
-10,789 Reduced 39.44%
16,568 $1.54 Million
Q4 2020

Feb 12, 2021

BUY
$79.17 - $111.47 $1.6 Million - $2.26 Million
20,242 Added 284.5%
27,357 $2.45 Million
Q3 2020

Nov 10, 2020

SELL
$81.91 - $134.94 $11.8 Million - $19.4 Million
-143,555 Reduced 95.28%
7,115 $735,000
Q2 2020

Aug 13, 2020

BUY
$54.33 - $89.52 $2.52 Million - $4.15 Million
46,380 Added 44.47%
150,670 $11.9 Million
Q1 2020

May 15, 2020

BUY
$49.34 - $68.76 $5.15 Million - $7.17 Million
104,290 New
104,290 $6.03 Million

Others Institutions Holding EBS

About Emergent BioSolutions Inc.


  • Ticker EBS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,861,500
  • Market Cap $542M
  • Description
  • Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...
More about EBS
Track This Portfolio

Track Westwood Holdings Group Inc Portfolio

Follow Westwood Holdings Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Westwood Holdings Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Westwood Holdings Group Inc with notifications on news.